Robert Scott

Dr. Robert A. Scott, MD, is a Chief Medical Officer, Head-Research & Development at ABIONYX Pharma SA and an Independent Director at Confo Therapeutics NV.
He is on the Board of Directors at Redx Pharma Plc, Confo Therapeutics NV, ArisGlobal LLC, Variant Bio, Inc., Draupnir Bio ApS and OncoSpherix, Inc. Dr. Scott was previously employed as a Lead Independent Director by Windtree Therapeutics, Inc., a VP & Head-Global Cardiovascular Development by Amgen, Inc., a Chief Medical Officer by Cerenis Therapeutics, Inc., a Chief Medical Officer & Head-Development by AbbVie SA, and a Principal by Pfizer Inc. He also served on the board at AtheroGenics, Inc. and Transcelerate Biopharma, Inc. He received his undergraduate degree from the University of Cape Town and a doctorate degree from the University of Cape Town.